CSL vs. MEDP
CSL (Carlisle Companies Incorporated) and MEDP (Medpace Holdings, Inc.) are both stocks. CSL operates in Building Products & Equipment (Industrials), while MEDP operates in Diagnostics & Research (Healthcare). Over the past 5 years, CSL returned 13.87%/yr vs 21.69%/yr for MEDP. At a 0.36 correlation, their price movements are largely independent.
Performance
CSL vs. MEDP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CSL achieves a 8.12% return, which is significantly higher than MEDP's -16.79% return.
CSL
- 1D
- 0.82%
- 1M
- 4.26%
- YTD
- 8.12%
- 6M
- 4.47%
- 1Y
- -2.49%
- 3Y*
- 14.36%
- 5Y*
- 13.87%
- 10Y*
- 14.57%
MEDP
- 1D
- -1.63%
- 1M
- 12.54%
- YTD
- -16.79%
- 6M
- -16.23%
- 1Y
- 56.69%
- 3Y*
- 28.75%
- 5Y*
- 21.69%
- 10Y*
- —
CSL vs. MEDP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CSL Carlisle Companies Incorporated | 8.12% | -12.26% | 19.14% | 34.26% | -4.08% | 60.64% | -1.96% | 63.10% | -10.31% | 4.51% |
MEDP Medpace Holdings, Inc. | -16.79% | 69.05% | 8.38% | 44.31% | -2.40% | 56.35% | 65.60% | 58.81% | 45.97% | 0.53% |
Correlation
The correlation between CSL and MEDP is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.34 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.38 |
Correlation (All Time) Calculated using the full available price history since Aug 11, 2016 | 0.36 |
The correlation between CSL and MEDP shifts across timeframes, from 0.22 (1 year) to 0.38 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CSL:
$14.13B
MEDP:
$13.54B
CSL:
$17.08
MEDP:
$15.63
CSL:
20.13
MEDP:
29.89
CSL:
0.52
MEDP:
0.90
CSL:
2.93
MEDP:
5.14
CSL:
8.55
MEDP:
22.62
CSL:
$4.98B
MEDP:
$2.68B
CSL:
$1.41B
MEDP:
$778.59M
CSL:
$1.17B
MEDP:
$572.96M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CSL vs. MEDP — Risk / Return Rank
CSL
MEDP
CSL vs. MEDP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Carlisle Companies Incorporated (CSL) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CSL | MEDP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.92 | ||
| Sortino ratioReturn per unit of downside risk | -1.79 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.32 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.16 | 1.48 | -1.64 |
| Martin ratioReturn relative to average drawdown | -0.27 | 3.28 | -3.55 |
Loading charts...
Drawdowns
CSL vs. MEDP - Drawdown Comparison
The maximum CSL drawdown since its inception was -64.56%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for CSL and MEDP.
Loading charts...
Drawdown Indicators
| CSL | MEDP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.56% | -42.87% | -21.69% |
Max Drawdown (1Y)Largest decline over 1 year | -31.67% | -36.61% | +4.94% |
Max Drawdown (3Y)Largest decline over 3 years | -37.72% | -39.38% | +1.66% |
Max Drawdown (5Y)Largest decline over 5 years | -37.72% | -42.87% | +5.15% |
Max Drawdown (10Y)Largest decline over 10 years | -38.68% | — | — |
Current DrawdownCurrent decline from peak | -27.08% | -24.69% | -2.39% |
Average DrawdownAverage peak-to-trough decline | -12.32% | -12.92% | +0.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.90% | 16.45% | +2.45% |
Volatility
CSL vs. MEDP - Volatility Comparison
Carlisle Companies Incorporated (CSL) has a higher volatility of 10.87% compared to Medpace Holdings, Inc. (MEDP) at 6.83%. This indicates that CSL's price experiences larger fluctuations and is considered to be riskier than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CSL | MEDP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.87% | 6.83% | +4.04% |
Volatility (6M)Calculated over the trailing 6-month period | 24.85% | 37.78% | -12.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.22% | 68.99% | -32.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.81% | 51.61% | -20.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.68% | 49.76% | -20.08% |
Dividends
CSL vs. MEDP - Dividend Comparison
CSL's dividend yield for the trailing twelve months is around 1.28%, while MEDP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL Carlisle Companies Incorporated | 1.28% | 1.31% | 1.00% | 1.02% | 1.09% | 0.86% | 1.31% | 1.11% | 1.53% | 1.27% | 1.18% | 1.24% |
MEDP Medpace Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CSL vs. MEDP - Financials Comparison
This section allows you to compare key financial metrics between Carlisle Companies Incorporated and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CSL vs. MEDP - Profitability Comparison
CSL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Carlisle Companies Incorporated reported a gross profit of 0.00 and revenue of 1.05B. Therefore, the gross margin over that period was 0.0%.
MEDP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.
CSL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Carlisle Companies Incorporated reported an operating income of 180.30M and revenue of 1.05B, resulting in an operating margin of 17.1%.
MEDP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.
CSL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Carlisle Companies Incorporated reported a net income of 127.70M and revenue of 1.05B, resulting in a net margin of 12.1%.
MEDP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.
Frequently Asked Questions
CSL and MEDP have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CSL has higher volatility (10.87%) compared to MEDP (6.83%). In terms of maximum drawdown, CSL dropped -64.56% vs MEDP's -42.87%.
MEDP currently has the higher Sharpe Ratio (0.78 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CSL and MEDP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer